BRIEF-Schnitzer Steel Industries Q3 adjusted earnings per share $0.56
* Schnitzer Steel Industries Inc - qtrly revenue $477 million versus $352 million Source text for Eikon: Further company coverage:
March 22 Ultragenyx Pharmaceutical Inc said on Wednesday its drug to treat patients with seizures did not meet the main goal in a mid-stage study.
The company said the study did not show statistical significance in reducing the frequency of seizures among patients treated with the drug compared to a placebo. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Shounak Dasgupta)
* Blackbaud to acquire leading charity crowdfunding platform JustGiving